Home/Filings/4/0001209191-10-061800
4//SEC Filing

Nye Gordon E 4

Accession 0001209191-10-061800

CIK 0001496268other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 6:59 PM ET

Size

32.8 KB

Accession

0001209191-10-061800

Insider Transaction Report

Form 4
Period: 2010-12-16
Nye Gordon E
Director
Transactions
  • Conversion

    Common Stock

    2010-12-16+122,951782,125 total
  • Exercise of In-Money

    Common Stock

    2010-12-16$6.51/sh+464$3,019823,531 total
  • Conversion

    Series C Preferred Stock

    2010-12-1631,7260 total
    Common Stock (31,726 underlying)
  • Conversion

    Common Stock

    2010-12-16+3,930575,365 total
  • Conversion

    Common Stock

    2010-12-16+38,621820,746 total
  • Conversion

    Series B Preferred Stock

    2010-12-1652,0830 total
    Common Stock (52,083 underlying)
  • Conversion

    Series D Preferred Stock

    2010-12-16122,9510 total
    Common Stock (122,951 underlying)
  • Exercise of In-Money

    Common Stock

    2010-12-16$6.51/sh+2,321$15,102823,067 total
  • Conversion

    Series A Preferred Stock

    2010-12-163,9300 total
    Common Stock (3,930 underlying)
  • Conversion

    Series H Preferred Stock

    2010-12-1634,2950 total
    Common Stock (34,295 underlying)
  • Exercise of In-Money

    Warrant

    2010-12-16$6.51/sh5,716$37,1920 total
    Exercise: $6.51From: 2010-05-25Exp: 2012-12-07Common Stock (5,716 underlying)
  • Conversion

    Common Stock

    2010-12-16+52,083627,448 total
  • Exercise of In-Money

    Warrant

    2010-12-16$6.51/sh1,143$7,4370 total
    Exercise: $6.51From: 2010-06-02Exp: 2012-12-07Common Stock (1,143 underlying)
  • Conversion

    Common Stock

    2010-12-16+31,726659,174 total
Footnotes (3)
  • [F1]Each outstanding share of the Issuer's Preferred Stock automatically converted to one share of Common Stock upon the closing of the Issuer's initial public offering.
  • [F2]Includes 4,326 shares of Series H Preferred Stock which were accrued as cumulative dividends and paid upon the closing of the Issuer's initial public offering on as-converted basis.
  • [F3]Represents the issuance of Common Stock upon the exercise of such warrant on a cashless basis upon the closing of the Issuer's initial public offering.

Issuer

REVA Medical, Inc.

CIK 0001496268

Entity typeother

Related Parties

1
  • filerCIK 0001399278

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 6:59 PM ET
Size
32.8 KB